3 recruiting. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 3 | 2 | Recruiting 2 |
Follow Hypesthesia: new trials by email Literature Review of Hypesthesia trials Research Report on Hypesthesia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) VMD-3866 Gel, Placebo Gel - Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain | Phase 2 | Recruiting | VM Therapeutics LLC | 16 | 2025-12-12 | 2026-10-21 |
| Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-18 |
| Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-25 |
Paresthesia (3) · Anxiety Disorders (2) · Depression (2) · Agnosia (1) · Cancer Pain (1) · Chronic Pain (1) · Disease (1) · Neuralgia (1) · Pain (1) · Peripheral Nerve Injuries (1)
Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Somatosensory Disorders (3) · Behavior (2) · Behavioral Symptoms (2) · Mental Disorders (2) · Neurobehavioral Manifestations (1) · Neuromuscular Diseases (1) · Pathologic Processes (1) · Perceptual Disorders (1) · Peripheral Nervous System Diseases (1) · Trauma, Nervous System (1)
Oxygen (2)
Bernardino Clavo, MD, PhD (2) · VM Therapeutics LLC (1)
Spain (2) · United Kingdom (1)
Bernardino Clavo, MD, PhD (2) · Himar Fabelo, BSc, PhD (1) · Jacob Lorenzo-Morales, Prof (1)